CFLAR and Alzheimer disease: Conversely, apoptosis protection achieved through siRNA silencing of DR4 and DR5 highlighted their active role downstream apoptotic pathways unveiling new targets in (i.e., c-FLIP, DR4, and DR5) for therapeutic intervention for AD.